Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion President & CEO acquired 4,500 shares (option exercise)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 417 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 1,423 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 1,702 shares (to pay taxes)
  7. 4 Exercise or conversion Director acquired 2,150 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
  12. 4 Exercise or conversion President & CEO acquired 12,467 shares (option exercise)
  13. 4 Exercise or conversion President & CEO acquired 13,717 shares (option exercise)
  14. 5 Insider Annual Insider Trading Report
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.48 ($4,800)
  18. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.61 ($6,112)
  19. 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 14,060 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 12,049 shares (to pay taxes)

Page 11 of 23 · 459 filings